Cargando…

Effectiveness of Intravenous Immunoglobulin Plus Plasmapheresis on Antibody-mediated Rejection or Thrombotic Microangiopathy in Iranian Kidney Transplant Recipient

BACKGROUND: Antibody mediated rejection (AMR) and thrombotic microangiopathy (TMA) after kidney transplantation are difficult to differentiate most of the times and both play important roles in kidney allograft loss. Common treatment strategies of these two conditions include plasmapheresis, intrave...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dashti-Khavidaki, Simin, Shojaie, Lida, Hosni, Amin, Khatami, Mohammad Reza, Jafari, Atefeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450162/ https://www.ncbi.nlm.nih.gov/pubmed/26034746 http://dx.doi.org/10.5812/numonthly.7(3)2015.27073

Ejemplares similares

Cytopenia Occurrence in Kidney Transplant Recipients Within Early Post-transplant Period
por: Jafari, Atefeh, et al.
Publicado: (2017)

Plasmapheresis in Sepsis-induced Thrombotic Microangiopathy: A Case Series
por: Upadhya, Sushmita RS, et al.
Publicado: (2020)

Clinical characteristics, triggering etiologies, and response of plasmapheresis in thrombotic microangiopathy in Taiwan
por: Chung, Ching-Hu, et al.
Publicado: (2021)

Tacrolimus Dose Requirement in Iranian Kidney Transplant Recipients within the First Three Weeks after Transplantation
por: Dashti-Khavidaki, S., et al.
Publicado: (2016)

Effects of pre-transplant L-carnitine supplementation on primary graft dysfunction in liver transplant recipients: a pilot, randomized, placebo-controlled clinical trial
por: Khajeh, Behrouz, et al.
Publicado: (2019)

Donor's Versus Recipient's Demographic Data for Estimating Kidney Function in Kidney Transplant Recipients
por: Nabiee, Morteza, et al.
Publicado: (2019)

Clinical Pharmacokinetics of Tacrolimus in Iranian Liver Transplant Recipients
por: Nasiri-Toosi, Zahra, et al.
Publicado: (2014)

Intravenous immunoglobulin for acute hemorrhagic leukoencephalitis refractory to plasmapheresis
por: Panchal, Apurva, et al.
Publicado: (2018)

Profound hyperacute cardiac allograft rejection rescue with biventricular mechanical circulatory support and plasmapheresis, intravenous immunoglobulin, and rituximab therapy
por: Kaczorowski, David J, et al.
Publicado: (2013)

Comparing the Effect of Immediate versus Delayed Initiation of Tacrolimus on Delayed Graft Function in Kidney Transplant Recipients: A Randomized Open-label Clinical Trial
por: Ghadimi, Maryam, et al.
Publicado: (2018)

Thrombotic Microangiopathy Secondary to Intravenous Abuse of Opana® ER
por: Thakur, Kamia, et al.
Publicado: (2017)

Relapsing thrombotic microangiopathy and intravenous sustained-release oxycodone
por: Nataatmadja, Melissa, et al.
Publicado: (2016)

Plasmapheresis Is Associated With Better Renal Outcomes in Lupus Nephritis Patients With Thrombotic Microangiopathy: A Case Series Study
por: Li, Qiu-Yu, et al.
Publicado: (2016)

Snakebite associated thrombotic microangiopathy: a systematic review of clinical features, outcomes, and evidence for interventions including plasmapheresis
por: Noutsos, Tina, et al.
Publicado: (2020)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

Thrombotic Microangiopathy Associated with Pazopanib in a Kidney Transplant Recipient
por: Kalla, Shabana, et al.
Publicado: (2021)

Thrombotic microangiopathy in children
por: Palma, Lilian Monteiro P., et al.
Publicado: (2022)

Plasma exchange in Immunoglobulin A nephropathy with thrombotic microangiopathy and acute cortical necrosis
por: Doddi, P., et al.
Publicado: (2016)

A quick algorithmic review on management of viral infectious diseases in pediatric solid organ transplant recipients
por: Moghadamnia, Marjan, et al.
Publicado: (2023)

Association Between Pre-Transplant Magnesemia and Post-Transplant Dysglycemia in Kidney Transplant Recipients
por: Alamdari, Azam, et al.
Publicado: (2020)

Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
por: Lanfranco, Luca, et al.
Publicado: (2017)

Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2020)

Biopsy-Proven Renal-Limited Thrombotic Microangiopathy in a Heart Transplant Recipient
por: Bharati, Joyita, et al.
Publicado: (2023)

Successful Desensitization of T cell Flow Cytometry Crossmatch Positive Renal Transplant Recipients Using Plasmapheresis and Super High-Dose Intravenous Immunoglobulin
por: Kakuta, Yoichi, et al.
Publicado: (2017)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
por: Grall, Maximilien, et al.
Publicado: (2021)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Thrombotic microangiopathy in renal allografts
por: Radha, S., et al.
Publicado: (2014)

Influenza-associated thrombotic microangiopathies
por: Bitzan, Martin, et al.
Publicado: (2017)

Acyclovir-induced thrombotic microangiopathy
por: Goli, R., et al.
Publicado: (2017)

Cancer-associated thrombotic microangiopathy
por: Govind Babu, K, et al.
Publicado: (2016)

Complement in Secondary Thrombotic Microangiopathy
por: Palma, Lilian Monteiro Pereira, et al.
Publicado: (2020)

Thrombotic Microangiopathy Syndrome in the ICU
por: Samy Modeliar, S., et al.
Publicado: (2006)

Thrombotic Microangiopathy Syndrome in the ICU
por: Samy Modeliar, S., et al.
Publicado: (2006)

COVID-19 and thrombotic microangiopathies
por: Tiwari, Nishant R., et al.
Publicado: (2021)

Thrombotic microangiopathy triggered by podocytopathy
por: Veríssimo, Rita, et al.
Publicado: (2021)

Thrombotic microangiopathies: An illustrated review
por: Abou‐Ismail, Mouhamed Yazan, et al.
Publicado: (2022)

Diagnosis and treatment of thrombotic microangiopathy
por: Thompson, Gemma L., et al.
Publicado: (2022)

Chemotherapy-Associated Thrombotic Microangiopathy
por: Aklilu, Abinet M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f285ausk89e9gkc0881skekk1k